Stryker Corporation (SYK) Stock Analysis — Fair Value, Risk & Moat Rating
NYQ · Healthcare · Medical Devices
Is Stryker Corporation a safe investment right now?
Stryker Corporation's Altman Z-Score of 4.63 places it in the safe zone. Our fair value estimate is $366.97 (Buy Zone). Moat rating: 3.4/5 stars.
Could Stryker Corporation go bankrupt? Altman Z-Score analysis
Z-Score of 4.63 is above 3.0, indicating the company is financially healthy by this metric.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives SYK's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.1455 | 1.2 | 0.17 |
| B · Retained Earnings / Total Assets | RE / TA | 0.4279 | 1.4 | 0.6 |
| C · EBIT / Total Assets | EBIT / TA | 0.107 | 3.3 | 0.35 |
| D · Market Cap / Total Liabilities | MCap / TL | 4.9613 | 0.6 | 2.98 |
| E · Revenue / Total Assets | Rev / TA | 0.525 | 1.0 | 0.53 |
How has SYK's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 5.2 | Safe |
| 2023 | 5.12 | Safe |
| 2024 | 5.02 | Safe |
| 2025 | 4.63 | Safe |
Source: Calculated from SYK's latest 10-K filing on SEC EDGAR.
What is Stryker Corporation actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $11.02 | Proprietary blend of reported actuals + analyst consensus, weighted by α |
| Last Year EPS | $8.40 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $14.96 | 27 analysts consensus |
| Trailing P/E | 39.2x | Current market pricing |
| Fair P/E (β discount) | 33.3x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Accelerating | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $419.11 (27 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Stryker Corporation have a durable competitive advantage?
Moat rating: 3.4/5.
What makes up SYK's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 4/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 3/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is SYK's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 10.5% | — |
| 2023 | 12.8% | Rising |
| 2024 | 11.4% | Declining |
| 2025 | 13.4% | Rising |
Source: ROIC calculated from SEC EDGAR filings.
Is Stryker Corporation's dividend safe?
Can Stryker Corporation afford its dividend?
Payout ratio is 40.5%. FCF covers the dividend 1.9x. 36 consecutive years of payments.
Stryker Corporation's key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $25.1B | $22.6B | $18.4B | Rising |
| Net Income | $3.2B | $3.0B | $2.4B | Rising |
| Free Cash Flow | $4.3B | $3.5B | $2.0B | Rising |
| Gross Margin | 64.0% | 63.9% | 62.8% | Stable |
Recent events that affect our SYK analysis
SYK earnings report scheduled
Upcoming report. Consensus EPS estimate: $2.98. Revenue estimate: $6.33B. Our current Fair Value: $366.97 — a significant beat or miss could shift this estimate.
SYK analyst consensus: 76% bullish (22 of 29 analysts)
8 Strong Buy, 14 Buy, 7 Hold, 0 Sell, 0 Strong Sell. Consensus target: $419.11 (27.3% upside). Compare with our independent Fair Value: $366.97.
SYK paid $0.8800/share dividend
Dividend Safety Grade: A. Payout ratio: 40.5%.
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
SYK beat EPS estimates by 1.7%
Reported EPS: $4.47 vs estimate $4.40. Earnings strength supports our Fair Value of $366.97 (11.4% above current price).
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK paid $0.8800/share dividend
Dividend Safety Grade: A. Payout ratio: 40.5%.
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
SYK beat EPS estimates by 1.9%
Reported EPS: $3.19 vs estimate $3.13. Earnings strength supports our Fair Value of $366.97 (11.4% above current price).
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK paid $0.8400/share dividend
Dividend Safety Grade: A. Payout ratio: 40.5%.
SYK filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
SYK beat EPS estimates by 1.9%
Reported EPS: $3.13 vs estimate $3.07. Earnings strength supports our Fair Value of $366.97 (11.4% above current price).
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK paid $0.8400/share dividend
Dividend Safety Grade: A. Payout ratio: 40.5%.
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
SYK beat EPS estimates by 4.0%
Reported EPS: $2.84 vs estimate $2.73. Earnings strength supports our Fair Value of $366.97 (11.4% above current price).
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK paid $0.8400/share dividend
Dividend Safety Grade: A. Payout ratio: 40.5%.
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK beat EPS estimates by 3.5%
Reported EPS: $4.01 vs estimate $3.87. Earnings strength supports our Fair Value of $366.97 (11.4% above current price).
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
SYK filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Stryker Corporation
What is Stryker Corporation stock price today?
Stryker Corporation (SYK) stock price is $329.35 as of the latest market close, traded on the NYSE exchange.
What does Stryker Corporation do?
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
What is Stryker Corporation market cap?
Stryker Corporation has a market capitalization of $126.14B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is SYK in?
Stryker Corporation operates in the Healthcare sector, specifically within the Medical Devices industry. It trades on the NYSE under the ticker symbol SYK.
Is SYK stock overvalued or undervalued?
Based on our valuation model, Stryker Corporation trades 10.2% below our fair value estimate — potentially undervalued.
- FairValueLabs Fair Value: $366.97
- Current Price: $329.35
- Valuation Zone: Buy Zone
What is SYK stock forecast and analyst target price?
Based on 27 Wall Street analysts, the consensus price target for Stryker Corporation is $419.11, implying upside of 27.3% from the current price.
- Analyst High Target: $469.00
- Analyst Low Target: $316.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Stryker Corporation revenue and earnings growing?
Here are the analyst consensus growth estimates for Stryker Corporation:
- Revenue growth (current year est.): 8.6%
- EPS growth (current year est.): 9.8%
- Revenue growth (next year est.): 8.5%
- EPS growth (next year est.): 11.9%
What are Stryker Corporation's key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $25.1B | Rising |
| Net Income | $3.2B | Rising |
| Free Cash Flow | $4.3B | Rising |
| Gross Margin | 64.0% | Stable |
What is SYK's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 39.2x
- Forward P/E (next 12 months est.): 19.7x
- FairValueLabs Fair P/E: 33.3x
How volatile is SYK stock?
Stryker Corporation has a beta of 0.93, meaning it is roughly in line with overall market volatility. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Stryker Corporation have?
Stryker Corporation's balance sheet shows:
- Total Cash: $4.10B
- Total Debt: $16.36B
- Net Cash Position: $-12.26B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is Stryker Corporation's free cash flow?
Stryker Corporation generated $4.17B in trailing twelve-month free cash flow (from $5.04B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does Stryker Corporation pay a dividend, and is it safe?
Yes, Stryker Corporation pays a regular dividend. Here are the key metrics:
- Dividend Yield: 1.0%
- Payout Ratio: 40.5%
- Consecutive Years Paid: 36
- 5-Year Dividend Growth: -19.4%
- FairValueLabs Safety Grade: A
Is Stryker Corporation at risk of going bankrupt?
Stryker Corporation's Altman Z-Score is 4.63, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Stryker Corporation have a durable competitive advantage?
Stryker Corporation scores 3.4/5 stars (Narrow moat) in our moat analysis:
- ROIC Stability: 4/5
- Gross Margin Trend: 3/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is SYK's return on equity (ROE)?
Stryker Corporation's return on equity is 15.1%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy SYK stock?
SYK shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol SYK
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is SYK a value stock or speculative?
FairValueLabs classifies Stryker Corporation as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of Stryker Corporation?
The current CEO of Stryker Corporation is Mr. Kevin A. Lobo.
What is SYK's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $8.40
- Forward EPS (next 12 months est.): $16.74
- Analyst consensus EPS (this year): $14.96
- Analyst consensus EPS (next year): $16.74
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
SYK analysis methodology: How we calculate fair value, Z-Scores, and moat ratings